Complement inhibitors as therapeutic agents

M. Kathryn Liszewski; V. Bala Subramanian; John P. Atkinson

doi:10.1016/s0197-1859(00)80025-4

Complement inhibitors as therapeutic agents

M. Kathryn Liszewski, V. Bala Subramanian, John P. Atkinson

Research output: Contribution to journal › Article

3 Scopus citations

Abstract

This report has described several currently evolving strategies and therapeutic agents designed to inhibit the complement system. Many others can be envisioned. Analagous to the utility of therapeutic agents that inhibit the coagulation cascade, it can be anticipated that complement inhibitors will find an important niche in our armamentarium of drugs to reduce undesirable inflammatory reactions.

Original language	English
Pages (from-to)	168-173
Number of pages	6
Journal	Clinical Immunology Newsletter
Volume	17
Issue number	12
DOIs	https://doi.org/10.1016/s0197-1859(00)80025-4
State	Published - Dec 1997

Access to Document

10.1016/s0197-1859(00)80025-4

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Complement inhibitors as therapeutic agents'. Together they form a unique fingerprint.

Cite this

Liszewski, M. K., Subramanian, V. B., & Atkinson, J. P. (1997). Complement inhibitors as therapeutic agents. Clinical Immunology Newsletter, 17(12), 168-173. https://doi.org/10.1016/s0197-1859(00)80025-4

@article{cc8890c524c94d7aa779f744b3aa7ed9,

title = "Complement inhibitors as therapeutic agents",

abstract = "This report has described several currently evolving strategies and therapeutic agents designed to inhibit the complement system. Many others can be envisioned. Analagous to the utility of therapeutic agents that inhibit the coagulation cascade, it can be anticipated that complement inhibitors will find an important niche in our armamentarium of drugs to reduce undesirable inflammatory reactions.",

author = "Liszewski, {M. Kathryn} and Subramanian, {V. Bala} and Atkinson, {John P.}",

year = "1997",

month = dec,

doi = "10.1016/s0197-1859(00)80025-4",

language = "English",

volume = "17",

pages = "168--173",

journal = "Clinical Immunology Newsletter",

issn = "0197-1859",

number = "12",

}

TY - JOUR

T1 - Complement inhibitors as therapeutic agents

AU - Liszewski, M. Kathryn

AU - Subramanian, V. Bala

AU - Atkinson, John P.

PY - 1997/12

Y1 - 1997/12

N2 - This report has described several currently evolving strategies and therapeutic agents designed to inhibit the complement system. Many others can be envisioned. Analagous to the utility of therapeutic agents that inhibit the coagulation cascade, it can be anticipated that complement inhibitors will find an important niche in our armamentarium of drugs to reduce undesirable inflammatory reactions.

AB - This report has described several currently evolving strategies and therapeutic agents designed to inhibit the complement system. Many others can be envisioned. Analagous to the utility of therapeutic agents that inhibit the coagulation cascade, it can be anticipated that complement inhibitors will find an important niche in our armamentarium of drugs to reduce undesirable inflammatory reactions.

UR - http://www.scopus.com/inward/record.url?scp=0007823453&partnerID=8YFLogxK

U2 - 10.1016/s0197-1859(00)80025-4

DO - 10.1016/s0197-1859(00)80025-4

M3 - Article

AN - SCOPUS:0007823453

VL - 17

SP - 168

EP - 173

JO - Clinical Immunology Newsletter

JF - Clinical Immunology Newsletter

SN - 0197-1859

IS - 12

ER -